Jorge Mangabeira de Souza Júnior
◽
Rodrigo Melo Kulchetscki
◽
Jaime Paula Pessoa Linhares Filho
◽
Eduardo Gomes Lima
◽
Carlos Vicente Serrano Junior
SUMMARY The treatment of patients with ST-segment elevation myocardial infarction concomitant with the presence of multivessel disease has been studied in several recent studies with the purpose of defining the need, as well as the best moment to approach residual lesions. However, such studies included only stable patients. The best therapeutic approach to cardiogenic shock secondary to acute coronary syndrome, however, remains controversial, but there are recommendations from specialists for revascularization that include non-event related injuries. Recently published, the CULPRIT-SHOCK study showed benefit of the initial approach only of the injury blamed for the acute event, in view of the multivessel percutaneous intervention, in the context of cardiogenic shock. In this perspective, the authors discuss the work in question, regarding methodological questions, limitations and clinical applicability.
Clinical Applicability of Assisted Circulation in the Treatment of Cardiogenic Shock Secondary to Myocardial Infarction : Crdiogenic Shock